Takeda Pharmaceutical Co., Ltd. (TAK)
18.34
+0.10
(+0.58%)
USD |
NYSE |
Aug 25, 11:33
Takeda Pharmaceutical Shareholders Equity (Quarterly) : 46.50B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.50B |
| March 31, 2026 | 46.70B |
| December 31, 2025 | 48.76B |
| September 30, 2025 | 48.28B |
| June 30, 2025 | 47.53B |
| March 31, 2025 | 46.38B |
| December 31, 2024 | 47.20B |
| September 30, 2024 | 48.38B |
| June 30, 2024 | 48.47B |
| March 31, 2024 | 48.06B |
| December 31, 2023 | 47.82B |
| September 30, 2023 | 47.38B |
| June 30, 2023 | 47.88B |
| March 31, 2023 | 47.74B |
| December 31, 2022 | 46.81B |
| September 30, 2022 | 46.38B |
| June 30, 2022 | 46.50B |
| March 31, 2022 | 46.82B |
| December 31, 2021 | 46.30B |
| September 30, 2021 | 47.72B |
| June 30, 2021 | 47.20B |
| March 31, 2021 | 46.81B |
| December 31, 2020 | 44.90B |
| September 30, 2020 | 44.22B |
| June 30, 2020 | 43.44B |
| Date | Value |
|---|---|
| March 31, 2020 | 43.75B |
| December 31, 2019 | 44.83B |
| September 30, 2019 | 45.02B |
| June 30, 2019 | 45.20B |
| March 31, 2019 | 46.82B |
| December 31, 2018 | 18.58B |
| September 30, 2018 | 19.09B |
| June 30, 2018 | 18.45B |
| March 31, 2018 | 18.78B |
| December 31, 2017 | 18.77B |
| September 30, 2017 | 18.53B |
| June 30, 2017 | 17.93B |
| March 31, 2017 | 17.00B |
| December 31, 2016 | 16.99B |
| September 30, 2016 | 17.96B |
| June 30, 2016 | 17.63B |
| March 31, 2016 | 17.34B |
| December 31, 2015 | 17.45B |
| September 30, 2015 | 17.70B |
| June 30, 2015 | 17.69B |
| March 31, 2015 | 17.82B |
| December 31, 2014 | 20.88B |
| September 30, 2014 | 22.46B |
| June 30, 2014 | 23.58B |
| March 31, 2014 | 22.52B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 10.48B |
| Ono Pharmaceutical Co., Ltd. | 5.334B |
| Astellas Pharma, Inc. | 11.95B |
| Sanofi | -- |
| Eisai Co., Ltd. | 5.578B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.37B |
| Total Liabilities (Quarterly) | 49.87B |
| Debt to Equity Ratio | 0.6536 |
| Current Ratio | 1.140 |
| Net Debt Paydown Yield | 1.43% |